Edwards Lifesciencesvs.ResMed
EW vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Edwards Lifesciences is about 1.5× larger than ResMed by market cap; ResMed trades at the lower P/E (21.1 vs 47.9); year to date, Edwards Lifesciences leads (−1.2% vs −5.9%).
Side by side
| EW | RMD | |
|---|---|---|
| Market cap | $48.2B | $32.1B |
| Price | $85.21 | $230.05 |
| Today | +1.2% | +1.5% |
| Return YTD | −1.2% | −5.9% |
| Return 1Y | +11.2% | −19.7% |
| Since June 26, 2026 | −6.1% | +14.9% |
| P/E | 47.9 | 21.1 |
| P/S | 7.4 | 5.7 |
| P/B | 4.5 | 4.9 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Edwards LifesciencesEW
Heart valves, delivered by catheter as with TAVR or implanted surgically.
Full EW profile →ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →More EW & RMD comparisons
Other head-to-heads in the Medtech & devices segment.
See where EW and RMD sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →